Navigation Links
ViewRay Wins NorTech Innovation Award

CLEVELAND, Feb. 16 /PRNewswire/ -- ViewRay, Inc., a privately held medical device company, has earned a NorTech Innovation Award for its advancements in radiation therapy technology for the treatment of cancer. ViewRay was honored for its unique combination of medical imaging and radiotherapy, which is designed to improve the effectiveness of cancer treatments. Radiation therapy is used to treat nearly two-thirds of today's cancer patients.

While radiation has proven critical in the fight against cancer, current radiotherapy technology has a major shortcoming: because patients' internal organs may shift during treatment, clinicians cannot determine precisely where the radiation is going in a patient's body. Organ motion may be significant enough to cause the radiation to miss the target and unnecessarily irradiate healthy tissue. To solve this problem, ViewRay is using a new combination of magnetic resonance imaging (MRI) and radiotherapy technology. The ViewRay system is being designed to allow clinicians to see where the radiation is delivered inside the patient moment by moment during the treatment, potentially reducing side effects and improving treatment success for patients with many different kinds of cancer. The ViewRay system is now in the final stages of development.

"It is a great honor to be recognized by NorTech," said ViewRay president and CEO Greg Ayers, MD, PhD. "Millions of people around the world die from cancer every year, and innovations in diagnostics and treatment are critical. We have studied the motion of tumors in lung, liver, prostate and other types of cancer, and we believe there's an opportunity for ViewRay technology to significantly improve treatments for many patients."

The NorTech Innovation Awards, sponsored by the Northeast Ohio Technology Coalition and Crain's Cleveland Business, annually recognize businesses and other organizations that transform technical and scientific knowledge into novel products, services and processes that result in a positive economic impact. For more information on the award program, visit

About ViewRay

ViewRay, Inc., of Cleveland, Ohio, is a privately held medical device company developing advanced radiation therapy technology for the treatment of cancer. Using MRI-guided radiotherapy, the ViewRay system is intended to provide continuous soft-tissue imaging during treatment. The system is designed so that clinicians -- for the first time -- will be able to see the actual radiation dose being delivered and adapt to changes in the patient's anatomy, potentially reducing side effects and improving outcomes. For more information, visit

ViewRay is a trademark of ViewRay, Inc.

SOURCE ViewRay, Inc.



SOURCE ViewRay, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hearst Business Media Names Dr. Charles Tuchinda Chief Innovation Officer, Healthcare
2. Pipeline/Commercial Insight: Supportive Care in Oncology - Innovation and Market Growth Limited to Bone Metastases Management and Emerging Supportive Care Challenges Reports Now Available on ReportsandReports
3. Young Innovations, Inc. Board of Directors Declares Quarterly Dividend
4. Young Innovations, Inc. Provides 4th Quarter Conference Call Details
5. GSK Announces Open Innovation Strategy to Help Deliver New and Better Medicines for People Living in the Worlds Poorest Countries
6. Lilly CEO Stresses Human Element in Driving Medical Innovation
7. China Sky One Medical, Inc.s AMI Diagnostic Kit Recognized as a National Innovation Project by NDRC
8. Inverness Medical Innovations Offers to Acquire Standard Diagnostics
9. Cardiac Science and Gust Bardy, MD Create Innovation Center for Primary Care Medicine
10. Inverness Medical Innovations to Present at the J.P. Morgan Healthcare Conference on January 12, 2010
11. Sonic Innovations, Inc. Donates $10,000 to Feeding America
Post Your Comments:
(Date:11/26/2015)... 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in the ... Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new 247-page ... therapeutic drug monitoring market, including emerging tests, technologies, ...
(Date:11/26/2015)... 2015 --> ... potential att använda SyMRI för att hitta ... patienter med multipel skleros (MS) eller hjärntumörmetastaser ... AB för att kunna använda SyMRI Research ... SyMRI kan man generera flera konstrastbilder från ...
(Date:11/26/2015)... , November 26, 2015 ... the "Self Administration of High Viscosity Drugs" ... ) has announced the addition of the ... report to their offering. --> Research ... addition of the "Self Administration of High ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% ... More than 3.7 billion people under the age of 50 – or 67% of the ... first global estimates of HSV-1 infection . , "The data shocks us highly!" said ...
(Date:11/27/2015)... DE (PRWEB) , ... November 27, 2015 , ... ... member of the well-respected Microsoft Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s ... an independent group of Microsoft Dynamics SL software users, partners, industry experts and ...
(Date:11/27/2015)... ... November 27, 2015 , ... The moment you stop ... not only fulfilling the needs of advisers and clients but going above and ... providing top-tier customer service. However, there's always room for improvement, which is why ...
(Date:11/27/2015)... ... ... CBD College is proud to announce that on November 20th, ... its Diagnostic Medical Sonography program. CBD College is honored to join this very short ... universities in the state of California make the cut. CBD College is officially the ...
(Date:11/27/2015)... , ... November 27, 2015 , ... Dr. Thomas ... Associates, Inc. and Dr. Tucker Bierbaum with Emergency Medicine at St., Joseph ... that both STEMI and Sepsis conditions present in similar ways and require time-critical intervention ...
Breaking Medicine News(10 mins):